CMAKY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where CMAKY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 10, 2024. You may want to consider a long position or call options on CMAKY as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CMAKY just turned positive on December 10, 2024. Looking at past instances where CMAKY's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
CMAKY moved above its 50-day moving average on December 09, 2024 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CMAKY crossed bullishly above the 50-day moving average on December 16, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 91 cases where CMAKY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CMAKY's P/B Ratio (0.199) is slightly lower than the industry average of (1.030). P/E Ratio (3.711) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (4.848) is also within normal values, averaging (2.366). Dividend Yield (0.079) settles around the average of (0.058) among similar stocks. P/S Ratio (0.938) is also within normal values, averaging (2.921).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMAKY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMAKY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.
Industry RegionalBanks
1 Day | |||
---|---|---|---|
FOREX / NAME | Price $ | Chg $ | Chg % |
NZDGBP | 0.45 | N/A | N/A |
New Zealand Dollar - United Kingdom Pound | |||
GMEZX | 11.51 | N/A | N/A |
GuideStone Funds Impact Equity Inv | |||
SMYIX | 24.14 | -0.04 | -0.17% |
Franklin Global Equity I | |||
APHQX | 15.26 | -0.04 | -0.26% |
Artisan Mid Cap Value Institutional | |||
LAMTX | 22.84 | -0.06 | -0.26% |
Lord Abbett Dividend Growth R5 |
A.I.dvisor tells us that CMAKY and PONT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMAKY and PONT's prices will move in lockstep.
Ticker / NAME | Correlation To CMAKY | 1D Price Change % | ||
---|---|---|---|---|
CMAKY | 100% | N/A | ||
PONT - CMAKY | 22% Poorly correlated | N/A | ||
CLST - CMAKY | 20% Poorly correlated | N/A | ||
CNBB - CMAKY | 16% Poorly correlated | N/A | ||
CIXPF - CMAKY | 10% Poorly correlated | -5.23% | ||
CIWV - CMAKY | 10% Poorly correlated | N/A | ||
More |